Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from SS Innovations International ( (SSII) ) is now available.
On November 6, 2025, SS Innovations International announced the successful completion of the first telesurgery using its SSi Mantra Tele Surgeon Console (TSC). This compact and portable console allows telesurgeries to be performed from various locations, including physician offices, without the need for a full operating room. The milestone surgery was conducted by Dr. Sudhir Srivastava from New Delhi, India, on a patient in Jaipur, India, highlighting the TSC’s ability to extend surgical expertise remotely. This development is expected to enhance patient access to surgical care and provide hospital networks with greater flexibility.
The most recent analyst rating on (SSII) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on SS Innovations International stock, see the SSII Stock Forecast page.
Spark’s Take on SSII Stock
According to Spark, TipRanks’ AI Analyst, SSII is a Neutral.
SS Innovations International’s stock score is primarily influenced by its strong technical momentum, which is offset by significant financial performance challenges, particularly in profitability and cash flow. The valuation is unattractive due to a negative P/E ratio, reflecting ongoing financial struggles. The absence of earnings call data and corporate events means these factors do not impact the score.
To see Spark’s full report on SSII stock, click here.
More about SS Innovations International
SS Innovations International, Inc. is a developer of innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally. The company’s product range includes the SSi Mantra surgical robotic system and the SSi Mudra surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. Headquartered in India, SS Innovations plans to expand its global presence with technologically advanced, user-friendly, and cost-effective solutions.
Average Trading Volume: 86,676
Technical Sentiment Signal: Buy
Current Market Cap: $1.46B
For an in-depth examination of SSII stock, go to TipRanks’ Overview page.